title: Kinetics of DNA adduct formation and removal in mouse hepatocytes following in vivo exposure to 5,9-dimethyldibenzo[c,g]carbazole.
abstract: 5,9-Dimethyldibenzo[c,g]carbazole (DMDBC), a potent mouse hepatocarcinogen, has been shown to induce a non-linear increase in mutant frequency in the liver of the transgenic MutaMouse. To gain insight into the mechanisms underlying the mutagenicity of DMDBC in vivo, DNA damage formation and removal were monitored in mouse hepatocytes over 4-144 h after a single skin application of 10 or 90 mg/kg DMDBC. DNA adducts were measured by (32)P-post-labeling. DNA repair was assessed by: (i) the unscheduled DNA synthesis (UDS) assay, which measures [(3)H]thymidine incorporation into hepatocyte DNA undergoing excision repair; (ii) the Comet assay, which detects DNA strand breaks transiently produced between the incision and rejoining steps of the excision repair process. A plateau of approximately 400 DNA adducts/10(8) nucleotides was reached 24 h after treatment with 10 mg/kg and remained unchanged until 144 h. UDS activity was significantly induced at 15 and 24 h, while no DNA strand breaks were observed at any sampling time. These results suggest that DNA repair mechanisms were efficiently induced and the formation of a high degree of DNA damage was avoided at this dose level. Following exposure to 90 mg/kg DMDBC, the number of DNA adducts increased sharply to a maximum at 24 h ( approximately 8000/10(8) nucleotides) and then declined to approximately 500/10(8) nucleotides at 144 h. UDS activity was markedly induced from 15 to 72 h. Low levels of DNA strand breaks were observed at 24 and 48 h. The formation of large numbers of DNA adducts and the emergence of DNA strand breaks despite a strong initial induction of UDS activity suggested that DNA repair mechanisms were saturated at this dose level. This phenomenon could partly account for the non-linear induction of gene mutations previously reported in the liver of the transgenic MutaMouse.
authors.affiliation: Rhône-Poulenc Rorer, Nonclinical Safety Assessment, 13 Quai Jules Guesde, BP 14, 94403 Vitry sur Seine Cedex and Institut Curie-Biologie, 91405 Orsay Cedex, France.
authors.forename: D
authors.initials: D
authors.lastname: Renault
authors.forename: D
authors.initials: D
authors.lastname: Brault
authors.forename: Y
authors.initials: Y
authors.lastname: Lossouarn
authors.forename: O
authors.initials: O
authors.lastname: Périn-Roussel
authors.forename: D
authors.initials: D
authors.lastname: Taras-Valéro
authors.forename: F
authors.initials: F
authors.lastname: Périn
authors.forename: V
authors.initials: V
authors.lastname: Thybaud
mesh_terms: D000818:Animals; D002227:Carbazoles / Q000633:toxicity*; D002274:Carcinogens, Environmental / Q000633:toxicity*; D018736:DNA Adducts / Q000378:metabolism*; D004249:DNA Damage; D004260:DNA Repair; D004261:DNA Replication; D007700:Kinetics; D008099:Liver / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D008822:Mice, Transgenic; D015203:Reproducibility of Results
chemical_list: D002227:Carbazoles; D002274:Carcinogens, Environmental; D018736:DNA Adducts; C039387:5,9-dimethyldibenzo(c,g)carbazole